Title : An evaluation of the efficacy and safety of Tofogliflozin for the treatment of type II diabetes.

Pub. Date : 2019 May

PMID : 30835599






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In patients with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or those at high risk for CVD, subsequently to lifestyle changes and metformin therapy, the administration of an SGLT-2 inhibitor with established benefits for cardiovascular outcome (CVOT) should be considered. Metformin solute carrier family 5 member 2 Homo sapiens